• Abriva - Dacriva

Abriva - Dacriva

0 reviews / Write a review

  • In Stock
  • Rs.11,020
  • Rs.2,800

Available Options

Name:Abriva - Dacriva
Company:CCL Pharma 
Therapeutic Segment:HEPATOLOGY


           Abriva ( Sofosbuvir 400mg ) For the treatment of chronic hepatitis C (CHC) infection as a component of a combination antiviral treatment regimen in adults.

           Dacriva ( Daclatasvir 60mg ) For the treatment of chronic hepatitis C virus (HCV) infections in adults in combination with Sofosbuvir, with or without Ribavirin.

Ask for Review

Review Button

Tags: Abriva / Dacriva